• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特市场七种品牌双氯芬酸钠片的药品质量。

Pharmaceutical quality of seven brands of diclofenac tablet on the Saudi market.

机构信息

Clinical Studies and Empirical Ethics Department, King Faisal Specialist Hospital and Research Centre, P O Box # 3354 (MBC 03), Riyadh, 11211, Saudi Arabia.

Alfaisal University College of Medicine, Riyadh, Saudi Arabia.

出版信息

BMC Res Notes. 2020 Nov 26;13(1):548. doi: 10.1186/s13104-020-05385-8.

DOI:10.1186/s13104-020-05385-8
PMID:33243292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7694918/
Abstract

OBJECTIVE

We previously reported the pharmaceutical quality of eight brands of 50 mg enteric-coated diclofenac sodium tablet available on the Saudi market. Here, we assess the quality of reference (R1) and four generic (G1-G4) brands of 50 mg immediate-release diclofenac potassium tablet and of reference (R2) and generic (G5) brands of 100 mg sustained-release diclofenac sodium tablet.

RESULTS

Weight variation (range as % difference from mean), active substance content (mean (SD) as % difference from label), breaking force [mean (SD)], and friability (as % weight loss) were 95-104% and 99-102%, 100.9% (3.4%) and 105.6 (4.2%), 12.2 (1.3) and 12.9 (1.8) kg, and 0.0014% and 0.0012%, for R1 and R2, respectively. For G1-G5, they were ≤ ± 2%, 98.8% (2.7%) to 109.2% (3.8%), 6.4 (0.6) to 13.3 (1.0) kg, and 0.0007% to 0.0261%, respectively. R1 and G1-G4 disintegrated within 04:50-17:20 min: seconds and released a mean of 89-100% of label active substance content by 60 min in buffer (pH 6.8). R2 and G5 did not disintegrate or dissolve in 0.1 N HCl for 2 h, disintegrated in buffer (pH 6.8) in 01:58-02:15 h: minutes, and fulfilled dissolution criteria (pH 7.5) for both United States Pharmacopoeia test-1 and test-2. Thus all seven brands met pre-specified quality criteria.

摘要

目的

我们之前报道了沙特市场上 8 种 50mg 肠溶片型双氯芬酸钠的药物质量。在此,我们评估了 50mg 速释型双氯芬酸钾对照品(R1)和 4 种仿制药(G1-G4)以及 100mg 控释型双氯芬酸钠对照品(R2)和仿制药(G5)的质量。

结果

重量差异(实测值与平均值的百分比差异范围)、活性成分含量(实测值与标签值的百分比差异的平均值)、断裂力[平均值(标准差)]和脆碎度(重量损失的百分比)分别为 95-104%和 99-102%、100.9%(3.4%)和 105.6(4.2%)、12.2(1.3)和 12.9(1.8)kg,以及 0.0014%和 0.0012%,分别为 R1 和 R2。对于 G1-G5,其范围分别为≤±2%、98.8%(2.7%)至 109.2%(3.8%)、6.4(0.6)至 13.3(1.0)kg,以及 0.0007%至 0.0261%。R1 和 G1-G4 在 04:50-17:20 分钟:秒内崩解,在缓冲液(pH6.8)中 60 分钟内释放出标签活性成分含量的 89-100%。R2 和 G5 在 0.1N HCl 中 2 小时内未崩解或溶解,在缓冲液(pH6.8)中 01:58-02:15 小时:分钟内崩解,并且满足美国药典测试 1 和测试 2 的溶出标准。因此,所有 7 个品牌均符合预先指定的质量标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684a/7694918/91eb6554cde4/13104_2020_5385_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684a/7694918/91eb6554cde4/13104_2020_5385_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684a/7694918/91eb6554cde4/13104_2020_5385_Fig1_HTML.jpg

相似文献

1
Pharmaceutical quality of seven brands of diclofenac tablet on the Saudi market.沙特市场七种品牌双氯芬酸钠片的药品质量。
BMC Res Notes. 2020 Nov 26;13(1):548. doi: 10.1186/s13104-020-05385-8.
2
Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation.在沙特阿拉伯销售的八种50毫克双氯芬酸钠肠溶片制剂:体外质量评估
BMC Res Notes. 2020 Sep 14;13(1):428. doi: 10.1186/s13104-020-05270-4.
3
Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia.评估在沙特阿拉伯销售的 9 种 500 毫克对乙酰氨基酚片剂品牌的质量。
BMC Res Notes. 2021 Jun 30;14(1):254. doi: 10.1186/s13104-021-05672-y.
4
In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.孟加拉国市场上主要品牌环丙沙星片剂的体外质量评估。
BMC Res Notes. 2017 May 30;10(1):185. doi: 10.1186/s13104-017-2507-y.
5
Comparative Quality Control Study of Different Brands of Diclofenac Sodium Tablet Available in Local and Government Pharmacies by In-Vitro Testing.通过体外测试对本地及政府药房中不同品牌双氯芬酸钠片进行的比较质量控制研究
Cureus. 2020 Nov 5;12(11):e11348. doi: 10.7759/cureus.11348.
6
Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.报告:孟加拉国市场上不同品牌双氯芬酸钠缓释基质片的体外溶出度研究
Pak J Pharm Sci. 2008 Jan;21(1):70-7.
7
Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric.使用Sureteric的双氯芬酸钠肠溶片的研制与稳定性评价
Pak J Pharm Sci. 2012 Jan;25(1):59-64.
8
Quality assessment of different brands of atorvastatin tablets available in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市市售不同品牌阿托伐他汀片的质量评估。
BMC Pharmacol Toxicol. 2022 Sep 13;23(1):69. doi: 10.1186/s40360-022-00598-y.
9
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.采用体内-体外-体内模拟方法理解肠溶片剂的体内性能:案例分析双氯芬酸。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1337-47. doi: 10.1016/j.ejpb.2013.09.009. Epub 2013 Sep 18.
10
In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka, Bangladesh.孟加拉国达卡部分社区药房中不同品牌埃索美拉唑片的体外比较质量评估
BMC Res Notes. 2018 Mar 20;11(1):184. doi: 10.1186/s13104-018-3285-x.

引用本文的文献

1
Quality assessment of different brands of atorvastatin tablets available in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市市售不同品牌阿托伐他汀片的质量评估。
BMC Pharmacol Toxicol. 2022 Sep 13;23(1):69. doi: 10.1186/s40360-022-00598-y.
2
Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia.评估在沙特阿拉伯销售的 9 种 500 毫克对乙酰氨基酚片剂品牌的质量。
BMC Res Notes. 2021 Jun 30;14(1):254. doi: 10.1186/s13104-021-05672-y.

本文引用的文献

1
Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation.在沙特阿拉伯销售的八种50毫克双氯芬酸钠肠溶片制剂:体外质量评估
BMC Res Notes. 2020 Sep 14;13(1):428. doi: 10.1186/s13104-020-05270-4.
2
Top 10 most used drugs in the Kingdom of Saudi Arabia 2010-2015.2010 - 2015年沙特阿拉伯王国使用最频繁的十大药物。
Saudi Pharm J. 2018 Feb;26(2):211-216. doi: 10.1016/j.jsps.2017.12.009. Epub 2017 Dec 15.
3
Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.
十四种速释口服药物的四十二种随机选择的市售仿制药的一般参考和仿制药-仿制药生物等效性。
BMC Pharmacol Toxicol. 2017 Dec 8;18(1):78. doi: 10.1186/s40360-017-0182-1.
4
What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs.人们对仿制药的真实看法是什么?关于利益相关者对仿制药认知的文献的系统综述与批判性评价。
BMC Med. 2015 Jul 29;13:173. doi: 10.1186/s12916-015-0415-3.
5
A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?医生和药剂师对通用药物使用观点的系统评价:全球面临哪些挑战?
Appl Health Econ Health Policy. 2015 Aug;13 Suppl 1(Suppl 1):S35-45. doi: 10.1007/s40258-014-0145-2.
6
Dissolution testing for generic drugs: an FDA perspective.仿制药的溶出度测试:FDA 的观点。
AAPS J. 2011 Sep;13(3):328-35. doi: 10.1208/s12248-011-9272-y. Epub 2011 Apr 9.
7
Bioeqivalence assessment of two domperidone 1 tablet formulations.两种多潘立酮1片制剂的生物等效性评估。
Arzneimittelforschung. 2007;57(5):269-73. doi: 10.1055/s-0031-1296617.
8
Bioequivalence study of two metformin formulations.两种二甲双胍制剂的生物等效性研究。
Arzneimittelforschung. 2007;57(4):192-5. doi: 10.1055/s-0031-1296605.
9
Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.两种奥美拉唑胶囊制剂在健康志愿者中的生物等效性评估。
Arzneimittelforschung. 2007;57(2):101-5. doi: 10.1055/s-0031-1296590.
10
Bioequivalence evaluation of two rosiglitazone tablet formulations.
Arzneimittelforschung. 2006;56(11):740-3. doi: 10.1055/s-0031-1296784.